Edition:
India

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

44.32USD
19 Jul 2019
Change (% chg)

$-0.16 (-0.36%)
Prev Close
$44.48
Open
$44.32
Day's High
$44.88
Day's Low
$44.26
Volume
95,027
Avg. Vol
124,773
52-wk High
$46.52
52-wk Low
$24.89

Latest Key Developments (Source: Significant Developments)

Cardiovascular Systems Q3 Earnings Per Share $0.02
Thursday, 2 May 2019 

May 1 (Reuters) - Cardiovascular Systems Inc ::CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2019 THIRD-QUARTER FINANCIAL RESULTS.Q3 EARNINGS PER SHARE $0.02.Q3 REVENUE $63.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $62.8 MILLION.SEES FY 2019 REVENUE UP 13 TO 14 PERCENT.SEES FY 2019 REVENUE $245 MILLION TO $247 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $-0.03 -- REFINITIV IBES DATA.INCREASES FISCAL 2019 REVENUE GUIDANCE TO UPPER HALF OF PREVIOUS RANGE.  Full Article

Cardiovascular Systems Reports Q2 EPS Of $0.01
Thursday, 31 Jan 2019 

Jan 30 (Reuters) - Cardiovascular Systems Inc ::CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2019 SECOND-QUARTER FINANCIAL RESULTS.Q2 EARNINGS PER SHARE $0.01.Q2 REVENUE $60.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $59.7 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.04 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE $243 MILLION TO $247 MILLION."REMAIN ON TRACK TO ACHIEVE MIDPOINT OF OUR FISCAL 2019 REVENUE GUIDANCE RANGE".SEES FISCAL 2019 NET LOSS EQUAL TO 1%-2% OF REVENUE.SEES POSITIVE ADJUSTED EBITDA FOR FISCAL 2019.  Full Article

Cardiovascular Systems, Aerolase Corp To Collaborate On Laser Atherectomy Technology
Tuesday, 31 Jul 2018 

July 31 (Reuters) - Cardiovascular Systems Inc ::CARDIOVASCULAR SYSTEMS, INC. AND AEROLASE CORP. SIGN COLLABORATIVE AGREEMENT FOR LASER ATHERECTOMY TECHNOLOGY.CARDIOVASCULAR SYSTEMS INC - UNDER TERMS OF AGREEMENT, CSI MADE AN UNDISCLOSED EQUITY INVESTMENT IN AEROLASE.CARDIOVASCULAR SYSTEMS INC - CSI WILL MAKE ADDITIONAL EQUITY INVESTMENTS IN AEROLASE AS DEVELOPMENT MILESTONES ARE MET.  Full Article

Cardiovascular Systems Says OrbusNeich 1.0mm Sapphire II PRO Coronary Balloon Granted FDA Clearance
Friday, 2 Mar 2018 

March 1 (Reuters) - Cardiovascular Systems Inc ::CARDIOVASCULAR SYSTEMS, INC. AND ORBUSNEICH ANNOUNCE FDA CLEARANCE OF THE FIRST AND ONLY 1.0MM CORONARY BALLOON IN THE U.S..CARDIOVASCULAR SYSTEMS INC - ANTICIPATES THAT ORBUSNEICH'S FULL BALLOON PRODUCT PORTFOLIO WILL BECOME AVAILABLE IN U.S. THROUGHOUT 2018 AND 2019.  Full Article

Cardiovascular Systems Appoints Jeff Points As CFO
Thursday, 8 Feb 2018 

Feb 7 (Reuters) - Cardiovascular Systems Inc ::CARDIOVASCULAR SYSTEMS, INC. APPOINTS JEFF POINTS AS CHIEF FINANCIAL OFFICER.CARDIOVASCULAR SYSTEMS INC - ‍POINTS SUCCEEDS LARRY BETTERLEY AS CFO AND WILL REPORT TO SCOTT WARD, CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER​.  Full Article

Cardiovascular Systems Q2 Loss Per Share $0.01
Thursday, 8 Feb 2018 

Feb 7 (Reuters) - Cardiovascular Systems Inc ::CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2018 SECOND-QUARTER FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.01.SEES FY 2018 REVENUE $215 MILLION TO $219 MILLION.Q2 REVENUE ROSE 5 PERCENT TO $52.6 MILLION.SEES Q3 2018 REVENUE $55 MILLION TO $56.5 MILLION.Q2 EARNINGS PER SHARE VIEW $-0.04, REVENUE VIEW $53.4 MILLION -- THOMSON REUTERS I/B/E/S.Q3 REVENUE VIEW $58.6 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Cardiovascular Systems Inc reports Q1 loss per share $0.06
Thursday, 26 Oct 2017 

Oct 25 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems Inc reports fiscal 2018 first-quarter financial results.Q1 loss per share $0.06.Q1 revenue $49.7 million versus I/B/E/S view $51 million.Q1 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S.Sees Q2 2018 loss per share $0.03 to $0.06.Sees FY 2018 revenue $226 million to $233 million.Sees Q2 2018 revenue $52.5 million to $54 million.Q2 earnings per share view $-0.01, revenue view $55.1 million -- Thomson Reuters I/B/E/S.FY2018 revenue view $227.6 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems announces anticipated revenue impact from hurricanes
Monday, 18 Sep 2017 

Sept 18 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems announces anticipated revenue impact from hurricanes Harvey and Irma.Cardiovascular Systems - ‍impact of hurricanes Harvey and Irma on procedure volumes in Greater Houstonm Florida will reduce fiscal 2018 Q1 revenues​.Cardiovascular Systems -‍potential revenue impact on CSI quarterly results magnified due to "small product portfolio and location and timing of storms"​.Cardiovascular Systems - ‍fiscal Q1 revenues are more heavily weighted in September, as procedure volumes begin to accelerate from summer levels​.Cardiovascular Systems Inc - ‍"Houston and Florida markets typically generate over 15% of CSI's revenues"​.Cardiovascular Systems - ‍co anticipates that the factors will reduce Q1 revenues below range of $52.6 million to $53.6 million provided on August 2, 2017​.  Full Article

Cardiovascular Systems Q4 earnings per share $0.02
Thursday, 3 Aug 2017 

Aug 2 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems, Inc. Reports fiscal 2017 fourth-quarter financial results.Q4 earnings per share $0.02.Q4 revenue $52.9 million versus I/B/E/S view $52 million.Sees q1 2018 loss per share $0.07 to $0.09.Sees q1 2018 revenue $52.6 million to $53.6 million.Q4 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S.  Full Article